Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rebecca Myschetzky"'
Autor:
Michael Bzorek, Michael Holmsgaard Kristensen, Andreas Kjaer, Andreas Klaus Pfeifer, Ulrich Knigge, Yin Wu, Rajendra Singh Garbyal, Palle Rasmussen, Rebecca Myschetzky
Publikováno v:
Diagnostics, Vol 3, Iss 4, Pp 344-355 (2013)
Peptide receptor radionuclide therapy (PRRT) is a relatively new mode of internally targeted radiotherapy currently in clinical trials. In PRRT, ionizing radioisotopes conjugated to somatostatin analogues are targeted to neuroendocrine tumors (NETs)
Externí odkaz:
https://doaj.org/article/1574fffef3e14a3791b87f946e6941df
Autor:
Henrik H. El Ali, Rasmus Poul Bodholdt, Jesper Tranekjær Jørgensen, Rebecca Myschetzky, Andreas Kjaer
Publikováno v:
Diagnostics, Vol 2, Iss 4, Pp 42-51 (2012)
The purpose of this study was to investigate whether a correction for annihilation photon attenuation in small objects such as mice is necessary. The attenuation recovery for specific organs and subcutaneous tumors was investigated. A comparison betw
Externí odkaz:
https://doaj.org/article/4c3eb1664af1470dbb8152dde4394aaa
Autor:
Ulrich Knigge, Michael Holmsgaard Kristensen, Andreas Kjaer, Palle Rasmussen, Rebecca Myschetzky, Yin Wu, Michael Bzorek, Rajendra Singh Garbyal, Andreas Klaus Pfeifer
Publikováno v:
Diagnostics, Vol 3, Iss 4, Pp 344-355 (2013)
Diagnostics; Volume 3; Issue 4; Pages: 344-355
Wu, Y, Pfeifer, A K, Myschetzky, R, Garbyal, R S, Rasmussen, P, Knigge, U, Bzorek, M, Kristensen, M H & Kjær, A 2013, ' Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor ', Diagnostics, vol. 3, no. 4, pp. 344-55 . https://doi.org/10.3390/diagnostics3040344
Diagnostics
Diagnostics; Volume 3; Issue 4; Pages: 344-355
Wu, Y, Pfeifer, A K, Myschetzky, R, Garbyal, R S, Rasmussen, P, Knigge, U, Bzorek, M, Kristensen, M H & Kjær, A 2013, ' Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor ', Diagnostics, vol. 3, no. 4, pp. 344-55 . https://doi.org/10.3390/diagnostics3040344
Diagnostics
Peptide receptor radionuclide therapy (PRRT) is a relatively new mode of internally targeted radiotherapy currently in clinical trials. In PRRT, ionizing radioisotopes conjugated to somatostatin analogues are targeted to neuroendocrine tumors (NETs)
Autor:
Andreas Kjaer, Rasmus Poul Bodholdt, Rebecca Myschetzky, Jesper Tranekjær Jørgensen, Henrik H. El Ali
Publikováno v:
Diagnostics, Vol 2, Iss 4, Pp 42-51 (2012)
Diagnostics; Volume 2; Issue 4; Pages: 42-51
Diagnostics
Diagnostics; Volume 2; Issue 4; Pages: 42-51
Diagnostics
The purpose of this study was to investigate whether a correction for annihilation photon attenuation in small objects such as mice is necessary. The attenuation recovery for specific organs and subcutaneous tumors was investigated. A comparison betw
Autor:
Andreas Kjaer, Jacob Madsen, Christina Schjoeth-Eskesen, Malene Brandt-Larsen, Jytte Oxboel, Henrik H. El-Ali, Rebecca Myschetzky
Publikováno v:
Nuclear medicine and biology. 41(3)
Introduction The aim of this study was to synthesize and perform a side-by-side comparison of two new tumor-angiogenesis PET tracers 68 Ga-NODAGA-E[c(RGDyK)] 2 and 64 Cu-NODAGA-E[c(RGDyK)] 2 in vivo using human xenograft tumors in mice. Human radiati